TY - JOUR
T1 - Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia
AU - Fonknechten, Nùria
AU - Mavel, Delphine
AU - Byrne, Paula
AU - Davoine, Claire Sophie
AU - Cruaud, Corinne
AU - Boentsch, Dominikus
AU - Samson, Delphine
AU - Coutinho, Paula
AU - Hutchinson, Michael
AU - McMonagle, Paul
AU - Burgunder, Jean Marc
AU - Tartaglione, Antonio
AU - Heinzlef, Olivier
AU - Feki, Imed
AU - Deufel, Thomas
AU - Parfrey, Nollaig
AU - Brice, Alexis
AU - Fontaine, Bertrand
AU - Prud'homme, Jean François
AU - Weissenbach, Jean
AU - Dürr, Alexandra
AU - Hazan, Jamilé
PY - 2000/3/1
Y1 - 2000/3/1
N2 - Autosomal dominant hereditary spastic paraplegia (AD-HSP) is a group of genetically heterogeneous neurodegenerative disorders characterized by progressive spasticity of the lower limbs. Five AD-HSP loci have been mapped to chromosomes 14q, 2p, 15q, 8q and 12q. The SPG4 locus at 2p21-p22 has been shown to account for ~40% of all AD-HSP families. SPG4 encoding spastin, a putative nuclear AAA protein, has recently been identified. Here, sequence analysis of the 17 exons of SPG4 in 87 unrelated AD-HSP patients has resulted in the detection of 34 novel mutations. These SPG4 mutations are scattered along the coding region of the gene and include all types of DNA modification including missense (28%), nonsense (15%) and splice site point (26.5%) mutations as well as deletions (23%) and insertions (7.5%). The clinical analysis of the 238 mutation carriers revealed a high proportion of both asymptomatic carriers (14/238) and patients unaware of symptoms (45/238), and permitted the redefinition of this frequent form of AD-HSP.
AB - Autosomal dominant hereditary spastic paraplegia (AD-HSP) is a group of genetically heterogeneous neurodegenerative disorders characterized by progressive spasticity of the lower limbs. Five AD-HSP loci have been mapped to chromosomes 14q, 2p, 15q, 8q and 12q. The SPG4 locus at 2p21-p22 has been shown to account for ~40% of all AD-HSP families. SPG4 encoding spastin, a putative nuclear AAA protein, has recently been identified. Here, sequence analysis of the 17 exons of SPG4 in 87 unrelated AD-HSP patients has resulted in the detection of 34 novel mutations. These SPG4 mutations are scattered along the coding region of the gene and include all types of DNA modification including missense (28%), nonsense (15%) and splice site point (26.5%) mutations as well as deletions (23%) and insertions (7.5%). The clinical analysis of the 238 mutation carriers revealed a high proportion of both asymptomatic carriers (14/238) and patients unaware of symptoms (45/238), and permitted the redefinition of this frequent form of AD-HSP.
UR - https://www.scopus.com/pages/publications/0034163576
U2 - 10.1093/hmg/9.4.637
DO - 10.1093/hmg/9.4.637
M3 - Article
C2 - 10699187
AN - SCOPUS:0034163576
SN - 0964-6906
VL - 9
SP - 637
EP - 644
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 4
ER -